Devyser Diagnostics AB (publ) (STO:DVYSR)
129.80
-2.20 (-1.67%)
Oct 31, 2025, 12:59 PM CET
Devyser Diagnostics AB Revenue
Devyser Diagnostics AB had revenue of 67.40M SEK in the quarter ending June 30, 2025, with 26.69% growth. This brings the company's revenue in the last twelve months to 235.10M, up 19.89% year-over-year. In the year 2024, Devyser Diagnostics AB had annual revenue of 216.90M with 28.12% growth.
Revenue (ttm)
235.10M
Revenue Growth
+19.89%
P/S Ratio
9.19
Revenue / Employee
1.99M
Employees
121
Market Cap
2.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 216.90M | 47.60M | 28.12% |
| Dec 31, 2023 | 169.30M | 42.70M | 33.73% |
| Dec 31, 2022 | 126.60M | 33.12M | 35.43% |
| Dec 31, 2021 | 93.48M | 27.79M | 42.31% |
| Dec 31, 2020 | 65.69M | 1.39M | 2.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |